Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene W Gerner

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammationEugene W Gerner, Frank L Meyskens
Biochimie|November 30, 2002
Polyamine-mediated post-transcriptional regulation of COX-2Michele Taylor Parker, Eugene W Gerner
Best Practice & Research. Clinical Gastroenterology|November 30, 2011
DFMO: targeted risk reduction therapy for colorectal neoplasiaChristina M Laukaitis, Eugene W Gerner
Journal of Biochemistry|January 24, 2006
Emerging concepts in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapyUpal K Basuroy, Eugene W Gerner
Oncotarget|October 18, 2019
GSTΠ stimulates caveolin-1-regulated polyamine uptake via actin remodelingTakeshi Uemura, George Tsaprailis, Eugene W Gerner
The Journal of Biological Chemistry|October 26, 2018
Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancerEugene W Gerner, Elizabeth Bruckheimer, Alfred Cohen
Molecular Carcinogenesis|June 6, 2013
Polyamines are oncometabolites that regulate the LIN28/let-7 pathway in colorectal cancer cellsEdwin A Paz, Bonnie LaFleur, Eugene W Gerner
The Biochemical Journal|November 3, 2005
Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cellsNaveen Babbar, Eugene W Gerner, Robert A Casero
Colorectal Cancer|September 16, 2014
Chemoprevention in patients with genetic risk of colorectal cancersChristina M Laukaitis, Steven H Erdman, Eugene W Gerner
Biological Chemistry|July 17, 2008
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cellsRebecca S Henkhaus, Eugene W Gerner, Natalia A Ignatenko
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammationEugene W Gerner, Frank L Meyskens
Biochimie|November 30, 2002
Polyamine-mediated post-transcriptional regulation of COX-2Michele Taylor Parker, Eugene W Gerner
Best Practice & Research. Clinical Gastroenterology|November 30, 2011
DFMO: targeted risk reduction therapy for colorectal neoplasiaChristina M Laukaitis, Eugene W Gerner
Journal of Biochemistry|January 24, 2006
Emerging concepts in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapyUpal K Basuroy, Eugene W Gerner
Oncotarget|October 18, 2019
GSTΠ stimulates caveolin-1-regulated polyamine uptake via actin remodelingTakeshi Uemura, George Tsaprailis, Eugene W Gerner
The Journal of Biological Chemistry|October 26, 2018
Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancerEugene W Gerner, Elizabeth Bruckheimer, Alfred Cohen
Molecular Carcinogenesis|June 6, 2013
Polyamines are oncometabolites that regulate the LIN28/let-7 pathway in colorectal cancer cellsEdwin A Paz, Bonnie LaFleur, Eugene W Gerner
The Biochemical Journal|November 3, 2005
Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cellsNaveen Babbar, Eugene W Gerner, Robert A Casero
Colorectal Cancer|September 16, 2014
Chemoprevention in patients with genetic risk of colorectal cancersChristina M Laukaitis, Steven H Erdman, Eugene W Gerner
Biological Chemistry|July 17, 2008
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cellsRebecca S Henkhaus, Eugene W Gerner, Natalia A Ignatenko
Pageof 9